Stay updated on Modakafusp Alfa in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Modakafusp Alfa in Multiple Myeloma Clinical Trial page.

Latest updates to the Modakafusp Alfa in Multiple Myeloma Clinical Trial page
- Check5 days agoChange Detected- Added related topics: Multiple myeloma and MedlinePlus Genetics to the study page.SummaryDifference0.1%

- Check12 days agoChange Detected- Removed the 'Multiple Myeloma' related topics and the MedlinePlus Genetics link from the Related Topics section.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics. Revision updated to v3.4.2 (superseding v3.4.1).SummaryDifference0.1%

- Check27 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.0%

- Check34 days agoChange DetectedThe sponsor is now listed as Teva Branded Pharmaceutical Products R&D LLC/Inc, replacing Takeda. New IPD sharing details outline data access, de-identification, and the contact for requests.SummaryDifference0.7%

- Check41 days agoChange DetectedThe page now includes a glossary toggle and related topics (e.g., MedlinePlus Genetics); several metadata fields and versioning information were updated or added (Results First Posted, Last Update Submitted/Posted, No FEAR Act Data, Revision v3.4.0) and older metadata entries were removed.SummaryDifference0.2%

Stay in the know with updates to Modakafusp Alfa in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Modakafusp Alfa in Multiple Myeloma Clinical Trial page.